Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury

Peptides ◽  
2014 ◽  
Vol 58 ◽  
pp. 26-29 ◽  
Author(s):  
Ding-Bo Yang ◽  
Wen-Hua Yu ◽  
Xiao-Qiao Dong ◽  
Quan Du ◽  
Yong-Feng Shen ◽  
...  
Injury ◽  
2014 ◽  
Vol 45 (5) ◽  
pp. 819-824 ◽  
Author(s):  
Daniel S. Epstein ◽  
Biswadev Mitra ◽  
Gerard O’Reilly ◽  
Jeffrey V. Rosenfeld ◽  
Peter A. Cameron

2014 ◽  
Vol 31 (4) ◽  
pp. 404-410 ◽  
Author(s):  
Deborah L. Donahue ◽  
Julia Beck ◽  
Braxton Fritz ◽  
Patrick Davis ◽  
Mayra J. Sandoval-Cooper ◽  
...  

2014 ◽  
Vol 29 (1) ◽  
pp. 118-122 ◽  
Author(s):  
Daniel S. Epstein ◽  
Biswadev Mitra ◽  
Peter A. Cameron ◽  
Mark Fitzgerald ◽  
Jeffrey V. Rosenfeld

2015 ◽  
Vol 32 (12) ◽  
pp. 982-983
Author(s):  
A Kehoe ◽  
R Bullough ◽  
K Ainsley ◽  
O Wigginton

Surgery ◽  
2015 ◽  
Vol 158 (3) ◽  
pp. 655-661 ◽  
Author(s):  
Lindley E. Folkerson ◽  
Duncan Sloan ◽  
Bryan A. Cotton ◽  
John B. Holcomb ◽  
Jeffrey S. Tomasek ◽  
...  

2016 ◽  
Vol 125 (5) ◽  
pp. 1229-1234 ◽  
Author(s):  
Aditya Vedantam ◽  
Jose-Miguel Yamal ◽  
Maria Laura Rubin ◽  
Claudia S. Robertson ◽  
Shankar P. Gopinath

OBJECT There is limited literature available to guide transfusion practices for patients with severe traumatic brain injury (TBI). Recent studies have shown that maintaining a higher hemoglobin threshold after severe TBI offers no clinical benefit. The present study aimed to determine if a higher transfusion threshold was independently associated with an increased risk of progressive hemorrhagic injury (PHI), thereby contributing to higher rates of morbidity and mortality. METHODS The authors performed a secondary analysis of data obtained from a recently performed randomized clinical trial studying the effects of erythropoietin and blood transfusions on neurological recovery after severe TBI. Assigned hemoglobin thresholds (10 g/dl vs 7 g/dl) were maintained with packed red blood cell transfusions during the acute phase after injury. PHI was defined as the presence of new or enlarging intracranial hematomas on CT as long as 10 days after injury. A severe PHI was defined as an event that required an escalation of medical management or surgical intervention. Clinical and imaging parameters and transfusion thresholds were used in a multivariate Cox regression analysis to identify independent risk factors for PHI. RESULTS Among 200 patients enrolled in the trial, PHI was detected in 61 patients (30.5%). The majority of patients with PHI had a new, delayed contusion (n = 29) or an increase in contusion size (n = 15). The mean time interval between injury and identification of PHI was 17.2 ± 15.8 hours. The adjusted risk of severe PHI was 2.3 times higher for patients with a transfusion threshold of 10 g/dl (95% confidence interval 1.1–4.7; p = 0.02). Diffuse brain injury was associated with a lower risk of PHI events, whereas higher initial intracranial pressure increased the risk of PHI (p < 0.001). PHI was associated with a longer median length of stay in the intensive care unit (18.3 vs 14.4 days, respectively; p = 0.04) and poorer Glasgow Outcome Scale scores (42.9% vs 25.5%, respectively; p = 0.02) at 6 months. CONCLUSIONS A higher transfusion threshold of 10 g/dl after severe TBI increased the risk of severe PHI events. These results indicate the potential adverse effect of using a higher hemoglobin transfusion threshold after severe TBI.


Sign in / Sign up

Export Citation Format

Share Document